U.S. stock futures retreated early Wednesday, led by declines in tech contracts following Alphabet's latest quarterly earnings release.

Alphabet shares slipped in after-hours trading after Google's core digital ad business failed to meet consensus estimates, raising questions over Big Tech ad demand.

Genmab equity rallied sharply following encouraging late-stage oncology data, reinforcing its pipeline strength in competitive solid tumor markets.

Major technology stocks led early market gains on Wednesday as investors positioned ahead of the Federal Reserve's closely watched policy announcement.

Riding unprecedented demand for high-bandwidth memory chips, South Korea's SK Hynix signals immense capital returns after posting blowout financial results.

Global markets face a pivotal test as the Federal Reserve convenes its policy meeting alongside a torrent of high-stakes quarterly earnings from Big Tech giants.

Japan's Nikkei 225 jumped 1.7% in a dynamic session driven by robust buying across semiconductor and technology equipment shares.

Global markets displayed sharp divergence as mega-cap tech surged on artificial intelligence momentum while Brazilian equities slumped amid fiscal uncertainty.

Disclosures reveal Anthropic staff hold an unusually high equity concentration, underscoring intense talent retention battles in the booming artificial intelligence sector.

Technology stocks advanced sharply as enterprise demand for Anthropic's latest AI models catalyzed broad gains across cloud providers and semiconductor manufacturers.

Institutional investors recalibrate positions as artificial intelligence spending, debt servicing in telecom, and streaming profitability reshape the TMT landscape.

Japan's Nikkei 225 dropped 0.5% during trading as profit-taking and global tech headwinds weighed heavily on chipmakers and consumer electronics manufacturers.